Endonovo Therapeutics Announces Effectiveness of Registration of Equity Credit Line and Ceasing Variable Convertible Note Financing Los Angeles, CA, July 21, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced the Company’s registration statement on Form S-1 relating...

Great Basin Announces Request to Withdraw S-1 Registration Statement and Amendment to $75 Million 2016 Convertible Note SALT LAKE CITY, Jan. 20, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSND), a molecular diagnostics company, announced today that it has submitted a request to the Securities and...

Cadiz Inc. Announces $10 Million Convertible Note Financing LOS ANGELES, April 26, 2016 (GLOBE NEWSWIRE) -- Cadiz Inc. (the “Company”), (NASDAQ:CDZI) announced today that it has entered into convertible note purchase agreements with new and existing...